Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Net income of $5.9 million and $11.2 million for the three and nine months ended September 30, 2025, respectively ...

The South African petrochemical giant Sasol on Tuesday carried out the experimental loading of the first batch of Liquefied Petroleum Gas (LPG), commonly known as cooking gas, produced in the southern ...

The latest edition of La Marató de 3Cat raised 10 million euros, which will fund 36 research projects on respiratory diseases ...

Seer’s presence at HUPO 2025 represents one of the most comprehensive demonstrations of its technology to date, with more than a dozen scientific presentations, including two invited talks in the ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...

A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.

Rhythm Pharmaceuticals said on Friday the U.S. Food and Drug Administration has extended the review period for expanded approval of its drug, Imcivree, as a treatment for a rare form of obesity.

After announcing earlier this week the appointment of Andreas Wallnöfer, PhD, MBA, to its Board of Directors, Optigo ...

Prenatal exposure to the insecticide chlorpyrifos causes widespread brain abnormalities and poorer motor skills in children.

Interim data from the IQIRVO ® (elafibranor) ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers and consistent trends in ...